Variability of Botulinum Toxins: Challenges and Opportunities for the Future
Autor: | Christine Rasetti-Escargueil, Michel R. Popoff, Emmanuel Lemichez |
---|---|
Přispěvatelé: | Toxines bactériennes - Bacterial Toxins, Institut Pasteur [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Université Paris Diderot - Paris 7 (UPD7), Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS) |
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Botulinum Toxins Health Toxicology and Mutagenesis MESH: Botulinum Toxins/toxicity [SDV]Life Sciences [q-bio] MESH: Neurotoxins/toxicity Neurotoxins lcsh:Medicine Computational biology [SDV.BC]Life Sciences [q-bio]/Cellular Biology [SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC] Review Biology botulinum neurotoxins (BoNTs) Toxicology MESH: Neurons/drug effects Antibodies 03 medical and health sciences 0302 clinical medicine BoNT variants [SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB] Animals Humans MESH: Animals Neurons MESH: Humans MESH: Antibodies subtypes lcsh:R [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology 3. Good health 030104 developmental biology [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology Biological warfare Chimeric molecules 030217 neurology & neurosurgery |
Zdroj: | Toxins Toxins, Vol 10, Iss 9, p 374 (2018) Toxins, MDPI, 2018, 10 (9), pp.374. ⟨10.3390/toxins10090374⟩ Toxins, 2018, 10 (9), pp.374. ⟨10.3390/toxins10090374⟩ |
ISSN: | 2072-6651 |
DOI: | 10.3390/toxins10090374⟩ |
Popis: | International audience; Botulinum neurotoxins (BoNTs) are the most potent known toxins, and are therefore classified as extremely harmful biological weapons. However, BoNTs are therapeutic drugs that are widely used and have an increasing number of applications. BoNTs show a high diversity and are divided into multiple types and subtypes. Better understanding of the activity at the molecular and clinical levels of the natural BoNT variants as well as the development of BoNT-based chimeric molecules opens the door to novel medical applications such as silencing the sensory neurons at targeted areas and dermal restoration. This short review is focused on BoNTs' variability and the opportunities or challenges posed for future clinical applications. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |